Drug Trial Radar · NCT00123461
Study of Safety and Efficacy of Doxercalciferol in Patients With Chronic Kidney Disease, Stage 3 or 4, and Secondary Hyperparathyroidism
Last checked: Nov 19, 2026Latest source record: May 5, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
70
Planned (sponsor's estimate)
Start
Jul 2005
Primary completion
Oct 2007
Study completion Oct 2007
Sponsor
- Lead sponsor
- Genzyme, a Sanofi CompanySanofi (SNY)
- Sponsor type
- Industry
- First posted
- Jul 25, 2005
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to demonstrate the safety and effectiveness of Hectorol® (doxercalciferol) capsules in treating patients with Stage 3 or Stage 4 chronic kidney disease (CKD) with secondary hyperparathyroidism who have vitamin D levels in the normal range. Previous studies with doxercalciferol were conducted in patients who had low levels of vitamin D.
Conditions
- Secondary Hyperparathyroidism
- Renal Failure
- Chronic Renal Insufficiency
Interventions
Hectorol (doxercalciferol capsules), 0.5mcgDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Laboratory measurement of intact parathyroid hormone (iPTH)Time frame: 6 months
Locations
19 sites in 2 countries. Site status is shown where the registry gives one.
AKDHC Medical Research Services
Phoenix, Arizona
UCLA Diabetes Reseach Center
Alhambra, California
Apex Research of Riverside
Riverside, California
George Washington University Hospital
Washington D.C., District of Columbia
Discovery Medical Research Group
Ocala, Florida
Nephrology Associates
Palm Beach Gardens, Florida
Georgia Kidney Associates, Inc.
Marietta, Georgia
Michigan Kidney Consultants, P.C.
Pontiac, Michigan
Twin Cities Clinical Research
Brooklyn Center, Minnesota
University of Rochester Medical Center
Rochester, New York
Montefiore Medical Center
The Bronx, New York
Wake Nephrology Associates, PA
Raleigh, North Carolina
Wake Forest University School of Medicine
Winston-Salem, North Carolina
Altru Health System Research Center
Grand Forks, North Dakota
DaVita Lewiston Dialysis Center
Lewiston, Pennsylvania
Temple University
Philadelphia, Pennsylvania
Virginia Commonwealth University
Richmond, Virginia
Instituto Renal del Este
Caguas, Puerto Rico
Jose Cangiano, MD
San Juan, Puerto Rico
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.